TechNavio recognizes the following companies as the key players in the Global Digital Breast Tomosynthesis Market: GE Healthcare, Hologic Inc., Internazionale Medico Scientifica Srl, and Siemens Healthcare.
Commenting on the report, an analyst from TechNavio’s team said: “The use of DBT to diagnose breast cancer in patients with dense breasts is an emerging trend in the Global DBT market. Although mammography still remains the best imaging technique for detecting breast cancer, it can fail to detect 37-70 percent of breast cancer cases in women with dense breasts. As a result, there can be a delay in diagnosis for women with dense breast tissues. DBT enables the removal of overlapping tissue artifacts, especially in dense breasts, and offers better screening sensitivity. Thus, increased use of DBT for patients with dense breasts will fuel the demand for DBT equipment in the Diagnostic industry.”
According to the report, one of the main drivers in this market is the increase in the incidence of breast cancer among women, which has led to an increase in demand for imaging equipment such as breast tomosynthesis devices.
Further, the report states that one of the major challenges faced by the market is the lack of reimbursement policies for breast imaging through DBT for breast cancer diagnosis.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/report/global-digital-breast-tomosynthesis-mark…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit https://www.technavio.com/healthcare-chemicals-food-retail
Follow us on Twitter @ Technavio